A multipart phase 1 study of the safety, pharmacodynamics and pharmacokinetics of ALG-055009, a novel thyroid hormone receptor beta (THR-β) agonist for metabolic dysfunction-associated steatohepatitis (MASH), in healthy participants

平台已收录预计检索 <10 秒

查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。

文献信息

题目: A multipart phase 1 study of the safety, pharmacodynamics and pharmacokinetics of ALG-055009, a novel thyroid hormone receptor beta (THR-β) agonist for metabolic dysfunction-associated steatohepatitis (MASH), in healthy participants
作者: Hakim Charfi, Benedetta Massetto, Megan Fitzgerald, Kha Le, Stanley Wang, Ifong Kan‐Eng, Meenakshi Venkatraman, Naqvi Mohammad, Lawrence Blatt, Tse‐I Lin, Sushmita M. Chanda, John Fry
发表年份: 2026
期刊 / 来源: Clinical Pharmacology in Drug Development
出版社: Wiley
DOI: 10.1002/cpdd.1606
文献类型: 学术文献
平台记录更新: 2026-09-10 15:47:18

本页由 Scihuhuan.com 学术互换提供文献检索、引用与获取指引；论文版权和出版身份归原出版方。